Display Settings:

Format

Send to:

Choose Destination

    Nat Clin Pract Oncol. 2005 Sep;2(9):434-5.

    Do cyclo-oxygenase 2 inhibitors increase the risk of cardiovascular events?

    Chan AT, Fuchs CS.

    Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02116, USA. achan@partners.org

    PMID: 16265007 [PubMed]

    Supplemental Content

    Click here to read Click here to read